FeesSafety
Pluang+

Elauwit reports 66% rise in recurring revenue, cuts expenses, and expands managed Wi-Fi in 31 states.

Company Fundamentals
19 Nov 2026, 02:27 WIB
The Motley Fool
View Source
Bullish
Elauwit reports 66% rise in recurring revenue, cuts expenses, and expands managed Wi-Fi in 31 states.

Elauwit announced a 66% year-over-year increase in monthly recurring revenue to $539,000 and a 19% sequential drop in operating expenses to $2.9 million in Q3 2026. The company grows its managed Wi-Fi network contracts with property owners, locking in long-term, high-margin subscription income while expanding across 31 states and Washington D.C. This strategy boosts property owners' net operating income and reduces service costs by hiring local employees. Elauwit is capitalizing on rapid adoption by real estate investment trusts, aiming to build local market density and expand recurring revenue through long-term contracts.

Elauwit reported a 66% year-over-year rise in monthly recurring revenue to $539,000, alongside a 19% sequential drop in operating expenses. For readers following the real estate sector, here is Pluang's market snapshot as of Nov 19, 2026 07:11 WIB: Among 47 priced US real estate stocks, 17 rose and 30 fell. Notable movers include IIPR at USD 50.59 with a 3.25% decline but 100% buy orders on Pluang, COMP up 2.91% to USD 10.10, and ARR down 2.83% at USD 10.64 with 95% buy orders. Typical hold times range from 10 to 136 days.

More News

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron Technology is showing strong financial growth, driven by its crucial role in AI infrastructure and multiyear deals with key tech companies. The company recently beat revenue expectations with a 379% year-over-year increase and projects even be...

Company Fundamentals
Bullish
1 hour ago
FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

The FDA has approved Livsayis™ (cemdisiran), the first and only siRNA therapy for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive. This subcutaneous treatment, administered four times a year, targ...

Market News
Bullish
1 hour ago
Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit reports 66% growth in monthly recurring revenue to $539K, cutting expenses and expanding managed Wi-Fi networks.

Elauwit announced a 66% year-over-year increase in monthly recurring revenue to $539,000 by the end of Q3 2026, driven by long-term contracts for managed Wi-Fi in apartment communities. The company also reduced operating expenses by 19% sequentially ...

Company Fundamentals
Bullish
1 hour ago
Montauk Renewables delays capital spending, seeks credit amendments amid operational challenges.

Montauk Renewables delays capital spending, seeks credit amendments amid operational challenges.

Montauk Renewables deferred up to $120 million in capital spending and is negotiating credit facility amendments due to operational delays at its North Carolina swine waste project. These delays have created short-term risks for debt covenants, requi...

Company Fundamentals
Neutral
1 hour ago
Palantir's revenue soars past $2B, outpacing UiPath's slower, seasonal growth in AI software sales.

Palantir's revenue soars past $2B, outpacing UiPath's slower, seasonal growth in AI software sales.

Palantir Technologies has shown rapid quarter-over-quarter revenue growth, reaching $2.3 billion in Q3 2026, driven by strong commercial adoption of its AI platform and expansion beyond government contracts. In contrast, UiPath's revenue growth is mo...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App